Mark A. Wyatt
Direktor/Vorstandsmitglied bei Femeda Ltd.
Profil
Mark A.
Wyatt is currently a Director at Femeda Ltd.
He previously held positions as a Non-Executive Director at Evgen Pharma Plc, Director-Investment at Enterprise Ventures Ltd., Investment Director at Enterprise Ventures Ltd., Investment Director at Mercia Fund Management Ltd., Director at Cizzle Biotechnology Ltd., Non-Executive Director at Evgen Ltd., Investment Director at Enterprise Ventures Group Ltd., Non-Executive Director at Optibiotix Health Plc, Investment Director at Mercia Asset Management Plc, Independent Non-Executive Director at MyHealthChecked Plc, Associate at Excalibur Fund Managers Ltd., Manager-Bioscience Ventures at IP2IPO Innovations Ltd., and Bioscience Ventures Manager at Touchstone Innovations Investment Management Ltd.
He received an undergraduate degree from the University of Bath, a doctorate from the University of Cambridge, and an MBA from the University of Warwick.
Aktive Positionen von Mark A. Wyatt
| Unternehmen | Position | Beginn |
|---|---|---|
Femeda Ltd.
 Femeda Ltd. Medical SpecialtiesHealth Technology Femeda Ltd. develops and manufactures medical devices to treat incontinence. It offers devices for electro stimulation of the pelvic floor and provides a pro-active treatment of bladder leakage. The company was founded by James Bradley and Alison Caroline Kibble in 2002 and is headquartered in Cramlington, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mark A. Wyatt
| Unternehmen | Position | Ende |
|---|---|---|
| MYHEALTHCHECKED PLC | Direktor/Vorstandsmitglied | 17.07.2018 |
Cizzle Biotechnology Ltd.
 Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Cizzle Biotechnology Ltd. develops therapeutic products for lung cancer. The firm promotes DNA replication and is involved in its organization and control. The company was founded by Dawn Coverley and Justin Ainscough in 2005 and is headquartered in York, the United Kingdom. | Direktor/Vorstandsmitglied | 25.04.2017 |
| THERACRYF PLC | Direktor/Vorstandsmitglied | 03.04.2017 |
Enterprise Ventures Ltd.
 Enterprise Ventures Ltd. Investment ManagersFinance Enterprise Ventures Ltd. (Enterprise Ventures) subsidiary of Enterprise Ventures Group Ltd was founded in 1996. The firm was headquartered in Preston, United Kingdom. | Private Equity Investor | 10.03.2016 |
| OPTIBIOTIX HEALTH PLC | Direktor/Vorstandsmitglied | 01.01.2016 |
Ausbildung von Mark A. Wyatt
| University of Warwick | Masters Business Admin |
| University of Cambridge | Doctorate Degree |
| University of Bath | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| THERACRYF PLC | Health Services |
| OPTIBIOTIX HEALTH PLC | Health Technology |
| MYHEALTHCHECKED PLC | Health Technology |
| MERCIA ASSET MANAGEMENT PLC | Finance |
| Private Unternehmen | 9 |
|---|---|
Enterprise Ventures Ltd.
Enterprise Ventures Ltd. Investment ManagersFinance Enterprise Ventures Ltd. (Enterprise Ventures) subsidiary of Enterprise Ventures Group Ltd was founded in 1996. The firm was headquartered in Preston, United Kingdom. | Finance |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Finance |
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
Enterprise Ventures Group Ltd.
 Enterprise Ventures Group Ltd. Investment ManagersFinance Enterprise Ventures Group Ltd. provides financing services to small businesses in England and Wales. It offers venture capital, growth capital, and loans to small and medium enterprises. The company was founded in 2001 and is headquartered in Preston, the United Kingdom. | Finance |
Cizzle Biotechnology Ltd.
Cizzle Biotechnology Ltd. BiotechnologyHealth Technology Cizzle Biotechnology Ltd. develops therapeutic products for lung cancer. The firm promotes DNA replication and is involved in its organization and control. The company was founded by Dawn Coverley and Justin Ainscough in 2005 and is headquartered in York, the United Kingdom. | Health Technology |
Femeda Ltd.
Femeda Ltd. Medical SpecialtiesHealth Technology Femeda Ltd. develops and manufactures medical devices to treat incontinence. It offers devices for electro stimulation of the pelvic floor and provides a pro-active treatment of bladder leakage. The company was founded by James Bradley and Alison Caroline Kibble in 2002 and is headquartered in Cramlington, the United Kingdom. | Health Technology |
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Finance |
Mercia Fund Management Ltd.
 Mercia Fund Management Ltd. Investment ManagersFinance Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain. | Finance |
IP2IPO Innovations Ltd.
 IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Commercial Services |
